US2010298543A1PendingUtilityA1

Mammalian zcytor 11

Assignee: ZYMOGENETICS INCPriority: Aug 5, 1997Filed: Mar 26, 2010Published: Nov 25, 2010
Est. expiryAug 5, 2017(expired)· nominal 20-yr term from priority
C07K 14/715
54
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Novel receptor polypeptides, polynucleotides encoding the polypeptides, and related compositions and methods are disclosed. The polypeptides comprise an extracellular domain of a cell-surface receptor that is expressed in pancreas, small intestine, colon and thymus. The polypeptides may be used within methods for detecting ligands that promote the proliferation and/or differentiation of these organs.

Claims

exact text as granted — not AI-modified
1 . An isolated antibody that specifically binds to a polypeptide consisting of amino acid residues 18 to 228 of SEQ ID NO:2. 
     
     
         2 . The antibody of  claim 1 , wherein said antibody is a monoclonal antibody. 
     
     
         3 . The antibody of  claim 1 , wherein said antibody is a single-chain antibody. 
     
     
         4 . The antibody of  claim 1 , wherein said antibody is an antigen-binding antibody fragment. 
     
     
         5 . The antibody of  claim 4 , wherein the antigen-binding fragment is a F(ab′) 2  or Fab fragment. 
     
     
         6 . The antibody of  claim 1 , wherein said antibody is a genetically engineered antibody.

Join the waitlist — get patent alerts

Track US2010298543A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.